Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Capital Expenditures: 2010-2012

Historic Capital Expenditures for Lexicon Pharmaceuticals (LXRX) over the last 2 years, with Dec 2012 value amounting to $113,000.

  • Lexicon Pharmaceuticals' Capital Expenditures fell 45.93% to $113,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $492,000, marking a year-over-year decrease of 59.20%. This contributed to the annual value of $1.0 million for FY2024, which is 119.36% up from last year.
  • Lexicon Pharmaceuticals' Capital Expenditures amounted to $113,000 in Q4 2012, which was up 126.00% from $50,000 recorded in Q3 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Capital Expenditures registered a high of $507,000 during Q1 2011, and its lowest value of $50,000 during Q3 2012.
  • Its 3-year average for Capital Expenditures is $226,800, with a median of $221,500 in 2011.
  • Data for Lexicon Pharmaceuticals' Capital Expenditures shows a maximum YoY tumbled of 72.53% (in 2012) over the last 5 years.
  • Lexicon Pharmaceuticals' Capital Expenditures (Quarterly) stood at $254,000 in 2010, then decreased by 17.72% to $209,000 in 2011, then plummeted by 45.93% to $113,000 in 2012.
  • Its last three reported values are $113,000 in Q4 2012, $50,000 for Q3 2012, and $95,000 during Q2 2012.